India’s Big Gene Therapy Push: CAR-T Treatment In Just One Day
From cutting gene therapy manufacturing timelines from months to a single day to reducing costs by nearly 70%, MedTherapy CEO Dr. Bikesh Verma says India is positioning itself as a major hub for affordable CAR-T and cancer gene therapies. In an exclusive conversation, Dr. Verma explains how technological advancements are helping make one of the world’s most expensive treatments more accessible, while the company also prepares to launch its own blood cancer therapy product pending government approval. He says the mission goes beyond business — aiming to make advanced cancer treatment affordable and globally competitive from India.
